Cardiovascular Outcomes# LEADER Trial (Liraglutide)# The LEADER trial (Marso et al., NEJM 2016) enrolled 9,340 patients with type 2 diabetes and high cardiovascular risk
Natures Sunshine will continue to focus on advancing the science of feeling better through clinically studied products and programs that optimize metabolic function and health through the microbiome, said Ms
Your pharmacist or prescribing provider, before it is used
It can simplify therapy for some people, but it still requires attention to meal timing, kidney function, B12 status, side effects, and other medicines
The distribution of protein intake across the day is as important as total daily amount for optimizing muscle protein synthesis and preservation during GLP-1 therapy